Longzen Pharmaceutical Co., Ltd

Shandong Longzen Pharmaceutical Co, Ltd, a subsidiary and manufacturing site of Suzhou Medinoah Co, Ltd. was established in December 2020. It is located in ZouPing National Economic and Technological Development Zone of Shandong Province. Covering an area of 40 acres with a construction area of square meters, the total investment has surpassed US$100 million. Upon the successful completion of the Phase 1 construction, Longzen presently commands an annual production capacity of 350 tons of alpha-Lipoic acid, 572 tons of other drug substances, 30 million bottles of injectables, and 2 billion tablets (capsules) of solid drug products. Shandong Longzen Pharmaceutical Co, Ltd. represents a modern pharmaceutical company that seamlessly integrates product research and development, manufacturing, sales and marketing. In Longzen, we offer an array of alpha-lipoic acids and R-(+)-lipoic acid in pharma and premium grades, catering to diverse required certifications and standards worldwide. These products find applications in various industries such as pharmaceutical, cosmetic, perfumery and more. In Longzen, we always ensure highest quality in all our products. We maintain a fully integrated process, including upstream manufacturing and sourcing of key raw materials. We also strictly adhere to Good Manufacturing Practices (GMP) throughout our entire process. As a result, our products boast an unmatched impurity profile in the market. In Longzen, we always believe excellent team shapes highest quality. Longzen's executive team members have more than 20 years of experience in drug research and development, with a particular emphasis on alpha-lipoic acid. In addition, Longzen maintains a dedicated R&D team capable of formulation R&D of lipoic acid to meet customer's requirements.